New Key Statistics Module, Z-Score and F-Score
OTCPK:TWAPF Key Ratios
Market Cap $ M | 918.60 |
Enterprise Value $ M | 2,006.49 |
P/E(ttm) | 8.80 |
PE Ratio without NRI | 11.36 |
Forward PE Ratio | -- |
Price/Book | 0.91 |
Price/Sales | 0.62 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.23 |
Revenue (TTM) $ M | 1,564.00 |
EPS (TTM) $ | 2.26 |
Beneish M-Score | -2.15 |
10-y EBITDA Growth Rate % | 10.00 |
5-y EBITDA Growth Rate % | 7.60 |
y-y EBITDA Growth Rate % | 75.70 |
EV-to-EBIT | 12.40 |
EV-to-EBITDA | 12.40 |
PEG | 1.49 |
Shares Outstanding M | 49.22 |
Net Margin (%) | 7.10 |
Operating Margin % | 7.74 |
Pre-tax Margin (%) | 10.73 |
Quick Ratio | 1.46 |
Current Ratio | 2.72 |
ROA % (ttm) | 4.04 |
ROE % (ttm) | 11.04 |
ROIC % (ttm) | 3.42 |
Dividend Yield % | -- |
Altman Z-Score | 1.87 |
TWAPF Number of Guru Trades
TWAPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:TWAPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:TWAPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TOWA Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:TWAPF
Total 0- 1